Principal Financial Group
TPTX

Principal Financial Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Principal Financial Group’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,506
Closed -$640K – 2609
2022
Q2 		$640K Buy
+8,506
New +$378K ﹤0.01% 2004
2022
Q1 		– Sell
-10,348
Closed -$493K – 2614
2021
Q4 		$493K Sell
10,348
-4,027
-28% -$180K ﹤0.01% 2125
2021
Q3 		$955K Sell
14,375
-2,280
-14% -$162K ﹤0.01% 2014
2021
Q2 		$1.3M Sell
16,655
-577
-3% -$42.6K ﹤0.01% 1992
2021
Q1 		$1.63M Sell
17,232
-457
-3% -$54.3K ﹤0.01% 1895
2020
Q4 		$2.16M Buy
17,689
+5,107
+41% +$560K ﹤0.01% 1785
2020
Q3 		$1.1M Buy
12,582
+279
+2% +$19.4K ﹤0.01% 1852
2020
Q2 		$795K Buy
12,303
+6,899
+128% +$398K ﹤0.01% 1873
2020
Q1 		$241K Buy
5,404
+173
+3% +$9.19K ﹤0.01% 2024
2019
Q4 		$326K Buy
+5,231
New +$249K ﹤0.01% 2040

Principal Financial Group's TPTX Position: Q3 2022 in Review

Principal Financial Group sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 8,506 shares — an estimated $640K sold.

Principal Financial Group first reported a position in TPTX in Q4 2019 and held it in 10 quarters. The position peaked at $2.16M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Principal Financial Group reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Principal Financial Group sold 8,506 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $640K.
  • Principal Financial Group first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Principal Financial Group's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.16M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Principal Financial Group's 13F filing for Q3 2022, filed 9 Nov 2022.